226 related articles for article (PubMed ID: 3527702)
1. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.
Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM
Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes.
Gemmell CG; Peterson PK; Schmeling D; Mathews J; Quie PG
Eur J Clin Microbiol; 1983 Aug; 2(4):327-34. PubMed ID: 6628373
[TBL] [Abstract][Full Text] [Related]
3. Interactions between polymorphonuclear leucocytes, Bacteroides sp, and Escherichia coli: their role in the pathogenesis of mixed infection.
Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
J Clin Pathol; 1986 Apr; 39(4):376-82. PubMed ID: 3517072
[TBL] [Abstract][Full Text] [Related]
4. Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis.
Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
J Clin Pathol; 1985 Jan; 38(1):86-91. PubMed ID: 3881478
[TBL] [Abstract][Full Text] [Related]
5. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
[TBL] [Abstract][Full Text] [Related]
6. Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus.
Veringa EM; Verhoef J
Chemotherapy; 1987; 33(4):243-9. PubMed ID: 3608624
[TBL] [Abstract][Full Text] [Related]
7. Clindamycin enhances opsonization of Staphylococcus aureus.
Milatovic D; Braveny I; Verhoef J
Antimicrob Agents Chemother; 1983 Sep; 24(3):413-7. PubMed ID: 6638997
[TBL] [Abstract][Full Text] [Related]
8. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of opsonophagocytosis of Bacteroides spp. by clindamycin in subinhibitory concentrations.
Veringa EM; Lambe DW; Ferguson DA; Verhoef J
J Antimicrob Chemother; 1989 Apr; 23(4):577-87. PubMed ID: 2745261
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
Santoro J; Kaye D; Levison ME
Antimicrob Agents Chemother; 1976 Jul; 10(1):188-90. PubMed ID: 984752
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.
Soriano F; Ponte MC; Gaspar MC
J Clin Pathol; 1982 Oct; 35(10):1150-2. PubMed ID: 6752209
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
Stratton CW; Weeks LS; Aldridge KE
Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
[TBL] [Abstract][Full Text] [Related]
13. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
Brook I; Coolbaugh JC; Walker RI; Weiss E
Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
[TBL] [Abstract][Full Text] [Related]
14. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria.
Wade BH; Kasper DL; Mandell GL
J Antimicrob Chemother; 1983 Oct; 12 Suppl C():51-62. PubMed ID: 6643341
[TBL] [Abstract][Full Text] [Related]
15. Regulation of protein A biosynthesis in Staphylococcus aureus by certain antibiotics: its effect on phagocytosis by leukocytes.
Gemmell CG; O'Dowd A
J Antimicrob Chemother; 1983 Dec; 12(6):587-97. PubMed ID: 6662837
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
[TBL] [Abstract][Full Text] [Related]
18. Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses.
Dunn DL; Barke RA; Ewald DC; Simmons RL
Infect Immun; 1985 May; 48(2):287-91. PubMed ID: 3886544
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.
Gemmell CG; Peterson PK; Schmeling D; Kim Y; Mathews J; Wannamaker L; Quie PG
J Clin Invest; 1981 May; 67(5):1249-56. PubMed ID: 7014632
[TBL] [Abstract][Full Text] [Related]
20. Effect of bacterial competition on the opsonization, phagocytosis, and intracellular killing of microorganisms by granulocytes.
Dijkmans BA; Leijh PC; Braat AG; van Furth R
Infect Immun; 1985 Jul; 49(1):219-24. PubMed ID: 3891626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
